Sandbox2: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 48: Line 48:
</div>}}
</div>}}
{{familytree | | | | | | | | | | | | | |!| | | | | | || | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | || | |}}
{{familytree | | | | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| | | | |}}
{{familytree | | | | | | | | | |,|-|-|-|^|-|-|-|.| | | | |}}
{{familytree | | | | | | D01 | | | | | | | | | | | | D02 | | | | D01= '''Stable patient'''| D02= '''Unstable patient'''}}
{{familytree | | | | | | | | | D01 | | | | | | D02 | | | | D01= '''Stable patient'''| D02= '''Unstable patient'''}}
{{familytree | | | | | | |!| | | | | | | | | | | | | |!| | | | }}
{{familytree | | | | | | | | | |!| | | | | | | |!| | | | }}
{{familytree | | | | | | E01 | | | | | | | | | | | | E02 | | | |  E01=❑ Assess the [[ECG]] | E02=❑ Urgent electrical [[cardioversion]]}}
{{familytree | | | | | | | | | E01 | | | | | | E02 | | | |  E01=❑ Assess the [[ECG]] | E02=❑ Urgent electrical [[cardioversion]]}}
{{familytree | | | | | | |!| | | | | | | }}
{{familytree | | | | | | | | | |!| | | | | | | }}
{{familytree | | |,|-|-|-|^|-|-|-|.| | | | | }}
{{familytree | | | | | |,|-|-|-|^|-|-|-|.| | | | | }}
{{familytree | | F01 | | | | | | F02 | | | | | F01=<div style="float: left; text-align: left;"> '''Orthodromic AVRT''' <br>
{{familytree | | | | | F01 | | | | | | F02 | | | | | F01=<div style="float: left; text-align: left;"> '''Orthodromic AVRT''' <br>
The impulse travels from the atrium to the ventricle through the AV node and returns to the atrium through the accesory pathway. 90-95% of [[WPW]]
The impulse travels from the atrium to the ventricle through the AV node and returns to the atrium through the accesory pathway. 90-95% of [[WPW]]


❑ Narrow QRS complexes <br>
❑ Narrow QRS complexes <br>
Line 62: Line 62:
</div>|
</div>|
F02=<div style="float: left; text-align: left;"> '''Antidromic AVRT''' <br>
F02=<div style="float: left; text-align: left;"> '''Antidromic AVRT''' <br>
The impulse travels from the atrium to the ventricle through the AV node and returns to the atrium through the accesory pathway. 90-95% of [[WPW]]
The impulse travels from the atrium to the ventricle through theaccesory pathway and from the ventricle to the atrium through the AV node. Less than 10% of [[WPW]]


❑ Wide QRS complexes <br>
❑ Wide QRS complexes <br>
Line 68: Line 68:
❑ Short PR interval more than one half of the tachycardia RR interval
❑ Short PR interval more than one half of the tachycardia RR interval
</div> }}
</div> }}
{{familytree | | | | | |!| | | | | | | |!| | | | | |}}
{{familytree | | | | | G01 | | | | | | G02 | | | | G01=<div style="float: left; text-align: left;"> '''Treatment.'''<ref name="Mehta-1988">{{Cite journal  | last1 = Mehta | first1 = D. | last2 = Wafa | first2 = S. | last3 = Ward | first3 = DE. | last4 = Camm | first4 = AJ. | title = Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia. | journal = Lancet | volume = 1 | issue = 8596 | pages = 1181-5 | month = May | year = 1988 | doi =  | PMID = 2897005 }}</ref><ref name="Jackman-1988">{{Cite journal  | last1 = Jackman | first1 = WM. | last2 = Friday | first2 = KJ. | last3 = Fitzgerald | first3 = DM. | last4 = Yeung-Lai-Wah | first4 = JA. | last5 = Lazzara | first5 = R. | title = Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia. | journal = Am J Cardiol | volume = 62 | issue = 19 | pages = 8L-19L | month = Dec | year = 1988 | doi =  | PMID = 3059792 }}</ref><ref name="Sung-1980">{{Cite journal  | last1 = Sung | first1 = RJ. | last2 = Elser | first2 = B. | last3 = McAllister | first3 = RG. | title = Intravenous verapamil for termination of re-entrant supraventricular tachycardias: intracardiac studies correlated with plasma verapamil concentrations. | journal = Ann Intern Med | volume = 93 | issue = 5 | pages = 682-9 | month = Nov | year = 1980 | doi =  | PMID = 7212475 }}</ref><br>
❑ Use [[Valsalva maneuver|Valsalva maneuvers]] <br><br>''If not effective initiate IV AV nodal blocking agent''<br><br>
❑ Administer [[Adenosine]]<br><br>''If not effective''<br><br>
❑ Administer [[Verapamil]]<br><br>''If not effective''<br><br>
❑ Administer [[Procainamide]]<br>
</div> |
G02=<div style="float: left; text-align: left;"> '''Treatment.'''<br>
❑ Administration of [[Procainamide]], [[Flecainide]] or [[Ibutilide]] is the prefered treatment<br>
❑ [[Adenosine]] should be used with caution because may produce [[AF]]<br>
</div>}}
{{familytree/end}}
{{familytree/end}}



Revision as of 16:07, 17 March 2014

|

Overview

Wolff-Parkinson-White syndrome (WPW) is a syndrome of pre-excitation of the ventricles of the heart due to an accessory pathway known as the Bundle of Kent.

Causes

Life Threatening Causes

Life-threatening causes include conditions which result in death or permanent disability within 24 hours if left untreated. Wolff-Parkinson-White syndrome can be a life-threatening condition and must be treated as such irrespective of the underlying cause.

Common Causes

WPW is a congenic disease

Managment

Initial Management

Shown below is an algorithm summarizing the initial management of supraventricular tachycardia according to the 2003 ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias.[1]

AVRT: AV reentrant tachycardia

 
 
 
 
 
 
 
 
 
 
 
 
Characterize the symptoms:
❑ Asymptomatic PalpitationsDyspnea
Fatigue Chest discomfort Lightheadedness
Syncope Polyuria

Characterize the timing of the symptoms:
❑ Onset
❑ Duration
❑ Frequency

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

❑ Examine the patient

❑ Monitor the blood pressure
❑ Monitor the heart rate

❑ Order and monitor the ECG
❑ Assess and support ABC
❑ Give oxygen if needed
❑ Treat reversible causes if identified

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stable patient
 
 
 
 
 
Unstable patient
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Assess the ECG
 
 
 
 
 
❑ Urgent electrical cardioversion
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Orthodromic AVRT

The impulse travels from the atrium to the ventricle through the AV node and returns to the atrium through the accesory pathway. 90-95% of WPW

❑ Narrow QRS complexes
❑ Ventricular rate between 150-250 bpm (or more) usually regular
❑ Short PR interval less than one half of the tachycardia RR interval

 
 
 
 
 
Antidromic AVRT

The impulse travels from the atrium to the ventricle through theaccesory pathway and from the ventricle to the atrium through the AV node. Less than 10% of WPW

❑ Wide QRS complexes
❑ Ventricular rate between 150-250 bpm (or more) usually regular
❑ Short PR interval more than one half of the tachycardia RR interval

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment.[2][3][4]

❑ Use Valsalva maneuvers

If not effective initiate IV AV nodal blocking agent

❑ Administer Adenosine

If not effective

❑ Administer Verapamil

If not effective

❑ Administer Procainamide

 
 
 
 
 
Treatment.

❑ Administration of Procainamide, Flecainide or Ibutilide is the prefered treatment
Adenosine should be used with caution because may produce AF

 
 
 

References

  1. "ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary". Retrieved 15 August 2013.
  2. Mehta, D.; Wafa, S.; Ward, DE.; Camm, AJ. (1988). "Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia". Lancet. 1 (8596): 1181–5. PMID 2897005. Unknown parameter |month= ignored (help)
  3. Jackman, WM.; Friday, KJ.; Fitzgerald, DM.; Yeung-Lai-Wah, JA.; Lazzara, R. (1988). "Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia". Am J Cardiol. 62 (19): 8L–19L. PMID 3059792. Unknown parameter |month= ignored (help)
  4. Sung, RJ.; Elser, B.; McAllister, RG. (1980). "Intravenous verapamil for termination of re-entrant supraventricular tachycardias: intracardiac studies correlated with plasma verapamil concentrations". Ann Intern Med. 93 (5): 682–9. PMID 7212475. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources